Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Altman, Edward I. | - |
dc.contributor.author | Brady, Brooks | - |
dc.contributor.author | Resti, Andrea | - |
dc.contributor.author | Sironi, Andrea | - |
dc.date.accessioned | 2008-05-26T22:40:17Z | - |
dc.date.available | 2008-05-26T22:40:17Z | - |
dc.date.issued | 2003-03 | - |
dc.identifier.uri | http://hdl.handle.net/2451/26580 | - |
dc.description.abstract | This paper analyzes the association between aggregate default and recovery rates on credit assets, and seeks to empirically explain this critical relationship. We examine recovery rates on corporate bond defaults, over the period 1982-2002. Our econometric univariate and multivariate models explain a significant portion of the variance in bond recovery rates aggregated across all seniority and collateral levels. The central thesis is that aggregate recovery rates are basically a function of supply and demand for the securities, with default rates playing a pivotal role. Such a link would bring about a significant increase in both expected and unexpected losses as measured by some widespread credit risk models, and would affect the procyclicality effects of the New Basel Capital Accord. Our results have also important implications for investors in corporate bonds and bank loans, and for all markets (e.g.,securitizations, credit derivatives, etc.) which depend on recovery rates as a key variable. | en |
dc.language.iso | en_US | en |
dc.relation.ispartofseries | FIN-03-006 | en |
dc.subject | credit rating | en |
dc.subject | capital requirements | en |
dc.subject | credit risk | en |
dc.subject | recovery rate | en |
dc.subject | defaul | en |
dc.subject | procyclicality | en |
dc.title | The Link between Default and Recovery Rates: Theory, Empirical Evidence and Implications | en |
dc.type | Working Paper | en |
Appears in Collections: | Finance Working Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FIN-03-006.pdf | 161.68 kB | Adobe PDF | View/Open |
Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.